The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype

Abstract Current breast cancer classification methods, particularly immunohistochemistry and PAM50, face challenges in accurately characterizing the HER2-low subtype, a therapeutically relevant entity with distinct biological features. This notable gap can lead to misclassification, resulting in ina...

詳細記述

書誌詳細

主要な著者:	Polina Turova, Vladimir Kushnarev, Oleg Baranov, Anna Butusova, Sofia Menshikova, Sheila T. Yong, Anna Nadiryan, Zoia Antysheva, Svetlana Khorkova, Mariia V. Guryleva, Alexander Bagaev, Jochen K. Lennerz, Konstantin Chernyshov, Nikita Kotlov
フォーマット:	Artigo
言語:	Inglês
出版事項:	Nature Portfolio 2025-02-01
シリーズ:	npj Breast Cancer
オンライン･アクセス:	https://doi.org/10.1038/s41523-025-00723-0
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!